Page last updated: 2024-08-24

1-hexacosanol and Liver Steatosis

1-hexacosanol has been researched along with Liver Steatosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Han, Y; Jia, Y; Kim, B; Kim, Y; Lee, JH; Lee, SJ; Seo, WD; Thach, TT; Wu, C	1

Other Studies

1 other study(ies) available for 1-hexacosanol and Liver Steatosis

Article	Year
Hexacosanol reduces plasma and hepatic cholesterol by activation of AMP-activated protein kinase and suppression of sterol regulatory element-binding protein-2 in HepG2 and C57BL/6J mice. Nutrition research (New York, N.Y.), 2017, Volume: 43 Topics: AMP-Activated Protein Kinases; Animals; Cholesterol; Diet, High-Fat; Fatty Alcohols; Fatty Liver; Hep G2 Cells; Hepatocytes; Hordeum; Humans; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Phosphorylation; Sterol Regulatory Element Binding Protein 2; Transcription Factors	2017

Article

Year

Hexacosanol reduces plasma and hepatic cholesterol by activation of AMP-activated protein kinase and suppression of sterol regulatory element-binding protein-2 in HepG2 and C57BL/6J mice.

Nutrition research (New York, N.Y.), 2017, Volume: 43

Topics: AMP-Activated Protein Kinases; Animals; Cholesterol; Diet, High-Fat; Fatty Alcohols; Fatty Liver; Hep G2 Cells; Hepatocytes; Hordeum; Humans; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Phosphorylation; Sterol Regulatory Element Binding Protein 2; Transcription Factors

2017